The Discounted Cash Flow (DCF) valuation of Neuren Pharmaceuticals Ltd (NEU.AX) is 19.77 AUD. With the latest stock price at 13.19 AUD, the upside of Neuren Pharmaceuticals Ltd based on DCF is 49.9%.
Based on the latest price of 13.19 AUD and our DCF valuation, Neuren Pharmaceuticals Ltd (NEU.AX) is a buy. buying NEU.AX stocks now will result in a potential gain of 49.9%.
| Range | Selected | |
| WACC / Discount Rate | 5.2% - 6.9% | 6.1% |
| Long-term Growth Rate | 2.0% - 4.0% | 3.0% |
| Fair Price | 13.04 - 47.53 | 19.77 |
| Upside | -1.1% - 260.3% | 49.9% |